Fundraising FoxMayo Clinic Ventures — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Cadence develops a neuromodulation system intended to be a more effective, less invasive treatment for people living with drug-refractory epilepsy.
BiotechDigital HealthHealthtechMedical DevicesSammamish, US
Kent Leyde(Executive Officer, Director, Promoter)inWarren Douglas Sheffield(Executive Officer, Director, Promoter)
Co-investorsJAZZ Venture PartnersLumira VenturesAngelini VenturesF-Prime CapitalIaso Ventures
Surgical navigation systems using spatial computing and AI for surgical precision.
BiotechNew York, US
Osamah Choudhry(Executive Officer, Director)inChristopher Morley(Executive Officer, Director)in
Co-investorsIntermountain HealthKoru CapitalCoalition OperatorsInitialized CapitalThrive Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.